Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature
Alicia Smart(Brigham and Women's Hospital), Jonathan D. Schoenfeld(Brigham and Women's Hospital)
Cited by 16
Related Papers
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids
|Cancer Discovery|2017|591
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
|Cell|2022|376
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
|Clinical Cancer Research|2020|372
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma
|JAMA Oncology|2020|350
Frameshift events predict anti–PD-1/L1 response in head and neck cancer
|JCI Insight|2018|279